NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $50,000 | -12.3% | 592 | -9.2% | 0.01% | 0.0% |
Q1 2022 | $57,000 | -66.7% | 652 | -66.6% | 0.01% | -66.7% |
Q4 2021 | $171,000 | +13.2% | 1,954 | +6.0% | 0.02% | 0.0% |
Q3 2021 | $151,000 | -6.8% | 1,844 | +3.8% | 0.02% | -7.7% |
Q2 2021 | $162,000 | +15.7% | 1,776 | +8.6% | 0.03% | +8.3% |
Q1 2021 | $140,000 | -11.4% | 1,636 | -2.5% | 0.02% | -17.2% |
Q4 2020 | $158,000 | – | 1,678 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |